FDA warns Sprout over Addyi Instagram post, clinical trial sponsor for lacking an IND

Regulatory NewsRegulatory NewsPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)Warning letters